Long-term Efficacy of Upstream Therapy With Lipophilic or Hydrophilic Statins on Antiarrhythmic Drugs in Patients With Paroxysmal Atrial Fibrillation Comparison Between Atorvastatin and Pravastatin:Comparison Between Atorvastatin and Pravastatin
スポンサーリンク
概要
- 論文の詳細を見る
There is little information available on the benefits of selection of statins as upstream therapy for the prevention of paroxysmal atrial fibrillation (AF). We compared the efficacy and safety of atorvastatin (A-group, n = 43) and pravastatin (P-group, n = 41) as upstream therapy in patients with paroxysmal AF and dyslipidemia. A total of 84 patients (45 men, mean age, 66 ± 9 years, mean follow-up, 49 ± 32 months) were retrospectively assigned to receive atorvastatin (n = 41;10 mg/day) or pravastatin (n = 43 ; 10 mg/day). Survival rates free from AF recurrence at 1, 6, 12, and 24 months were 93%, 74%, 60%, and 53% in A-group, and 88%, 49%, 37%, and 29%, respectively, in P-group (P = 0.029, A-group versus P-group). Survival rates free from conversion to permanent AF at 12, 36, 60, and 90 months were 100%, 100%, 98%, and 95% in A-group, and 100%, 95%, 88%, and 83%, respectively, in P-group (P = 0.063, A-group versus P-group). Using a logistic regression model, atorvastatin was found to be associated with a significantly reduced risk of AF recurrence in comparison to pravastatin (unadjusted odds ratio [OR] = 0.27, 95% confidence interval 0.11-0.68, P = 0.005). This association remained significant after adjustment for potentially confounding variables (OR = 0.26, 95% CI 0.08-0.86, P = 0.027). Using a logistic regression model, atorvastatin was not associated with a significantly reduced risk of converting to permanent AF in comparison to pravastatin (unadjusted OR = 0.29, 95% CI 0.05-1.50, P = 0.138), but this association did show a significant difference after adjustment for potentially confounding variables in a multivariate model (OR = 0.08, 95% CI 0.06-0.96, P = 0.046). Adverse effects requiring discontinuation of statins were observed in 1 case (2%, myalgia) in A-group, and 1 case (2%, elevation in CPK level ≥ 500 IU/L) in P-group, respectively (P = NS, A-group versus P-group). Atorvastatin, a lipophilic statin, was considered to be more effective in preventing recurrence of paroxysmal AF and conversion to permanent AF than pravastatin, a hydrophilic statin.
著者
-
Sato Yoshihiro
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Tachibana Hideaki
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Komatsu Takashi
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Nakamura Motoyuki
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Ozawa Mahito
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
-
Kunugita Fusanori
Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine
-
Kunugita Fusanori
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
-
Nakamura Motoyuki
Division of Cardioangiology, Department of Internal Medicine, Iwate Medical University
-
Tachibana Hideaki
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
関連論文
- Relationship Between CHADS2 Score and Ischemic Stroke During Rhythm Control Therapy for Paroxysmal Atrial Fibrillation
- Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients
- Cardiovascular Risk Factors in Hemodialysis Patients : Results from Baseline Data of Kaleidoscopic Approaches to Patients with End-stage Renal Disease Study
- Plasma B-Type Natriuretic Peptide Level and Cardiovascular Events in Chronic Kidney Disease in a Community-Based Population
- Comparison of Long-Term Prognostic Evaluation Between Pre-Intervention Thrombolysis and Primary Coronary Intervention : A Prospective Randomized Trial : Five-Year Results of the IMPORTANT Study
- PJ-816 Is There Difference in Neo-intimal Hyperplasia between Drug-Eluting and Bare- Metal Stent : Optical Coherence Tomography and Integrated-Backscatter Intravascula-Ultrasound (IB-IVUS) study(PJ137,Intravascular Imagings 1 (I),Poster Session (Japanese)
- PJ-755 LDL Cholesterol/HDL Cholesterol Ratio Relate to Lipid Pool Volume in Coronary Artery Plaque IB IVUS Study(PJ127,Intravascular Imagings 2 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-193 What Levels of Plasma BNP are Related to Increased Risk of Onset of Cardiovascular Events in the General Population?(PJ033,Preventive Medicine/Epidemiology/Education 1 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese
- PJ-138 Long-term Prognostic Evaluation between Pre-intervention Thrombolysis and Direct Coronary-Intervention in Acute ST-Elevation Myocardial Infarction (STEMI) Patients : A Prospective Randomized Trial(PJ023,ACS/AMI (Clinical/Pathophysiology/Treatment/B
- OJ-228 Intensive Lipid-lowering Therapy with Atorvastatin Decreases Plasma Leptin with Improving Angiogenic Factors in Patients with Coronary Artery Disease(OJ38,Atherosclerosis (Clinical/Treatment) (IHD),Oral Presentation (Japanese),The 73rd Annual Scien
- OJ-176 Prehypertension is an Indicator of High Prevalence of Albuminuria, and a Predictor of Cardiovascular Events in the General Population(OJ30,Hypertension, Clinical (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Ci
- OJ-171 Assessment of Small Size Stent Patency using 320-Slice Multidetector Computed Tomography : Comparison with Quantitative Coronary Angiography and Intravascular Ultrasound(OJ29,CT/MRI (New Technology) (I),Oral Presentation (Japanese),The 73rd Annual
- OJ-091 Is Metabolic Syndrome a Useful Predictor for Cardiovascular Events and Death in the Rural Population?(OJ16,Metabolic Syndrome (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OJ-012 Is Plasma B-type Natriuretic Peptide Measurement Valid for Prediction of Cardiovascular Events and Death in Obese Subjects?(OJ02,Obesity/SAS (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-262 Effects of Atrovastatin on MicroRNA-22/222 Levels and Number of Endothelial Progenitor Cells Obtained from Patients with Coronary Artery Disease(OE45,Angina Pectoris (Clinical, Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Mee
- OE-173 Hemodialysis Patients have 7 to 20-fold Higher Mortality Risks and 11 to 31-fold Higher Incidence Rates of Acute Myocardial Infarction(OE30,Preventive Medicine/Epidemiology/Education (H),Oral Presentation (English),The 73rd Annual Scientific Meetin
- OE-004 Augment Effect of a Combined Treatment of Statin and Angiotensin 2 Receptor Blocker on Circulating Adiponectin in Coronary Artery Disease(OE01,Cardiovascular Pharmacology (Clinical) (H),Oral Presentation (English),The 73rd Annual Scientific Meeting
- FRS-058 Effect of Intensive Lipid-lowering Therapy on Telomere Erosion in Endothelial Progenitor Cells Obtained from Patients with Coronary Artery Disease(FRS12,New Approaches to Atherosclerosis Research (IHD),Featured Research Session (English),The 73rd
- PJ-558 Mortality and Incidence Rates of Myocardial Infarction among Japanese Hemodialysis Patients : Results from 2-year Follow-up Data of 1145 Patients(Preventive medicine/Epidemiology/Education(07)(H),Poster Session(Japanese),The 72nd Annual Scientific
- PJ-368 Does Low Grade Inflammation Increase Heart Rate? : Possible Mechanism for Association between Elevated Heart Rate and Cardiovascular Events(Preventive medicine/Epidemiology/Education(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meetin
- PJ-163 Elevated C-Reactive Protein Level is Associated with Atrial Fibrillation: A Community-Based Cross-Sectional Study(Preventive medicine/Epidemiology/Education(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulat
- PJ-425 Enalapril Enhances the Efficacy of Antiarrhythmic Drugs in Patients with Paroxysmal Atrial Fibrillation and Ischemic Heart Disease(PJ072,Atrial/Supraventricular Arrhythmia (Clinical/Treatment) 2 (A),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-424 Upstream Therapy with Antiarrhythmic Drugs and Statin Had a High Degree of Efficacy in Female Patients with Paroxysmal Atrial Fibrillation(PJ072,Atrial/Supraventricular Arrhythmia (Clinical/Treatment) 2 (A),Poster Session (Japanese),The 73rd Annual
- PJ-412 Different Pharmacological Action on the Dispersion of Ventricular Repolarization between Intravenous Nifekalant and Amiodarone Therapy(PJ070,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) 1 (A),Poster Session (Japanese),The 73rd Annual Scien
- PJ-019 Combination Therapy with Enalapril and Pravastatin on Antiarrhythmic Drugs in Patients with Paroxysmal Atrail Fibrillation(PJ003,Atrial/Supraventricular Arrhythmia (Clinical/Diagnosis) (A),Poster Session (Japanese),The 73rd Annual Scientific Meetin
- PJ-009 Relationship between the Efficacy of Bepridil Therapy and Plasma Concentration of Atrial Natriuretic Peptide in Patients with Paroxysmal Atrial Fibrillation(PJ002,Atrial/Supraventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Jap
- PE-323 Usefulness of 320-Slice Multidetector Computed Tomography to Assess In-Stent Restenosis : Comparison with Quantitative Coronary Angiography and Intravascular Ultrasound(PE054,CT/MRI (New Technology) (I),Poster Session (English),The 73rd Annual Scie
- PE-060 Is Japanese Guideline of Antithrombotic Therapy Valid to Prevent Ischemic Stroke for Patients with Nonvalvular Paroxysmal Atrial Fibrillation?(PE010,Thromboembolism/Antithrombotic Therapy/Thrombolysis 1 (IHD),Poster Session (English),The 73rd Annua
- PE-056 CHADS2 Score is a Useful Scheme for Risk Stratification of Thromboembolism in Japanese Patients with Paroxysmal Atrial Fibrillation(PE010,Thromboembolism/Antithrombotic Therapy/Thrombolysis 1 (IHD),Poster Session (English),The 73rd Annual Scientifi
- A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation
- PJ-590 Relationship between heart failure and plasma concentrations of atrial naturiuretic peptide in patients with paroxysmal atrial fibrillation and diabetes mellitus(Arrhythmia, diagnosis/Pathophysiology/EPS(10)(A),Poster Session(Japanese),The 72nd Ann
- PJ-404 Efficacy of antiarrhythmic drugs therapy in preventing AF recurrence and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation(Arrhythmia, therapy(25)(A),Poster Session(Japanese),The 72nd Annual Scientific
- PE-262 Combination therapy with Bepridil and Enarapril prevents the development of atrial structural remodeling in patients with paroxysmal atrial fibrillation(Arrhythmia, therapy(13)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Ja
- PE-261 Efficacy of combination therapy with Enalapril on antiarrhythmic drugs in patients with atrial fibrillation ; relationship to the circadian variation of onset.(Arrhythmia, therapy(13)(A),Poster Session(English),The 72nd Annual Scientific Meeting of
- PE-145 Long-term cardiovascular prognosis in patients with paroxysmal atrial fibrillation ; Comparison between the groups with and without underlying structural heart disease(Arrhythmia, therapy(12)(A),Poster Session(English),The 72nd Annual Scientific Me
- Long-term Efficacy of Combination Therapy with Anti-arrhythmic Agents and Pravastatin in Patients with Paroxysmal Atrial Fibrillation
- PJ-292 Relationship between Long-term Cardiovascular Prognosis and Efficacy of Antiarrhythmic Drugs Therapy in Patients with Paroxysmal Atrial Fibrillation and Diabetes Mellitus(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Ci
- PJ-290 Efficacy of Intravenous Cibenzoline and Pilsicainide Administered Prior to Electrical Cardioversion in Patients with Lone and Persistent Paroxysmal Atrial Fibrillation(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Circu
- PJ-197 The Efficacy of Antiarrhythmic Drugs Therapy (Bepridil, Pilsicainide, Flecainide) with Regard to Structural Remodeling in Patients with Paroxysmal Atrial Fibrillation(Arrhythmia, diagnosis/pathophysiology/EPS-11, The 71st Annual Scientific Meeting
- PJ-196 The Combination Therapy with Amiodarone and Enalapril in patients with Paroxysmal Atrial Fibrillation Prevents the Development of Structural Remodeling(Arrhythmia, diagnosis/pathophysiology/EPS-11, The 71st Annual Scientific Meeting of the Japanese
- OJ-186 The Combination Therapy with Pravastatin and Enarapril Enhances the Efficacy of Antiarrhythmic Drugs in Preventing Recurrence of Paroxysmal Atrial Fibrillation(Arrhythmia, therapy-08, The 71st Annual Scientific Meeting of the Japanese Circulation S
- Clinical Profiles, Efficacy of Antiarrhythmic Drug Therapy, and Cardiovascular Prognosis in Patients With First Detected Paroxysmal Atrial Fibrillation
- Efficacy of Amiodarone for Preventing the Recurrence of Symptomatic Paroxysmal and Persistent Atrial Fibrillation After Cardioversion
- Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation : Analysis Based on Time of Onset
- 4 Cost Effectiveness of Exercise Cardiac Rehabilitation in Patients with Cardiovascular Disease(Costs of Clinical Practice in Cardiovascular Diseases,Symposium 8 (SY8) (H),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-317 CKD is Associated with Impairment of Arterial Elastic Property Independently of Conventional Atherosclerotic Risk Factors in the General Population(PJ054,Kidney/Renal Circulation/CKD 3 (H),Poster Session (Japanese),The 73rd Annual Scientific Meetin
- OE-417 Association between Oxidative DNA Damage and Telomere Shortening in Endothelial Progenitor Cells in Metabolic Syndrome Patients with Coronary Artery Disease(Atherosclerosis, clinical(02)(IHD),Oral Presentation(English),The 72nd Annual Scientific Me
- OE-325 Local Expression of Toll Like Receptor 4 at the Site of Ruptured Plaques in Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical(pathophysiology)(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of t
- PJ-149 Telomere Shorting was Related to Oxidative DNA Damage in Circulating Endothelial Progenitor Cells Obtained from Patients with Coronary Heart Disease(Acute coronary syndrome, basic/clinical-8, The 71st Annual Scientific Meeting of the Japanese Circu
- PJ-022 Altered Profile of Cytokines/Chemokine at the Site of Ruptured Plaque in Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-033 Association between Toll-like Receptor 8 Expression and Adverse Clinical Outcomes in Patients with Enterovirus-associated Dilated Cardiomyopathy(Molecular Determinants for the Development of Cardiomyopathy(M),Featured Research Session,The 72nd Ann
- OJ-006 Local Activated Tumor Necrosis Factor-α Converting Enzyme in Ruptured Plaque Contributes to Systemic Inflammation in Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-2, The 71st Annual Scientific Mee
- OE-234 Activation of Toll-like Receptor 4 in Monocytes is associated with Heart Failure after Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-1 (IHD) OE39,Oral Presentation (English),The 70th Anniversary Annual Scientif
- FRS-076 Eplerenone, a Novel Mineralocorticoid Receptor Antagonist, Inhibits Tumor Necrosis Factor-α Shedding Process in Monocytes from Patients with Congestive Heart Failure(Clinical Heart Failure, Diagnosis and Treatment-1 (M) FRS16,Featured Research Ses
- Activated Tumor Necrosis Factor-α Shedding Process is Associated with In-hospital Complication in Patients with Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Pathophysiology) 4 (IHD), The 69th Annual Scientific Meeting of the Japanese
- C-reactive Protein Co-expresses with Tumor Necrosis Factor-α in Myocardium in Human Dilated Cardiomyopathy(Heart Failure, Clinical 8 (M) The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Myocardial Osteopontin Expression is Associated with Collagen Fibrillogenesis in Human Dilated Cardiomyopathy(Myocardial Disease, Cardiomyopathy and Myocarditis (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-443 Inhibitory Effect of Low Dose Pioglitazone on the In-stent Restenosis in Patients with Acute Myocardial Infarction and Type 2 Diabetes(Acute myocardial infarction, clinical (diagnosis/treatment)-9 (IHD) PJ75,Poster Session (Japanese),The 70th Anniv
- PE-104 Anemia and Chronic Kidney Disease in the General Population ; A High Risk Group Characterized by High Plasma B-type Natriuretic Peptide(Kidney/Renal circulation(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circu
- OE-222 Chronic Kidney Disease is Associated with Increased Serum C-reactive Protein Level : A Cross-sectional Study of the General Population(Kidney/Renal circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Cir
- Mortality Risk Attributable to Atrial Fibrillation in Middle-Aged and Elderly People in the Japanese General Population : Nineteen-Year Follow-up in NIPPON DATA80
- A Community Based Epidemiological and Clinical Study of Hospitalization of Patients With Congestive Heart Failure in Northern Iwate, Japan
- PJ-656 Albuminuria is an Independent Predictor for the Onset of Cardiovascular Events in the General Population(Kidney/Renal circulation-5, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-491 Predictive Value of B-type Natriuretic Peptide, C-reactive Protein, and Urinary Albumin on the Onset of Heart Failure in the Community(Heart failure, clinical-13, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-228 Dietary Intake of Saturated Fatty Acid not only Exacerbates Dyslipidemia but also Increases Serum CRP Levels in Japanese General Population(Preventive medicine/Epidemiology/Education-2, The 71st Annual Scientific Meeting of the Japanese Circulation
- OJ-093 Increased Serum C-reactive Protein is a Potent Independent Predictor of Ischemic Cerebrovascular Events in Men but not in Women(Cerebrovascular circulation / Stroke-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-603 Enhanced Asymmetric Dimethylarginine Synthesis in the Atrium of a Canine Atrial Fibrillation Model : A Possible Role in Endocardial Remodeling(Arrhythmia, basic-5 (A) PJ101,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of
- PJ-208 Left Ventricular Dyssynchrony by Tissue Doppler Echocardiography as a Predictor of Prognosis after Cardiac Resynchronization Therapy for Advanced Heart Failure(Heart failure, clinical-15 (M) PJ35,Poster Session (Japanese),The 70th Anniversary Annua
- OJ-354 Sinus Venosa Region as an Anatomical and Not Functional Obstacle in Isthmus-dependent Atrial Flutter(Arrhythmia, diagnosis/pathophysiology/EPS-4 (A) OJ59,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Ci
- Randomized Crossover Study of the Long-Term Effects of Pilsicainide and Cibenzoline in Preventing Recurrence of Symptomatic Paroxysmal Atrial Fibrillation : Influence of the Duration of Arrhythmia Before Therapy(Clinical Investigation)
- OJ-092 Predictive Value of Plasma B-type Natriuretic Peptide for Ischemic Stroke in a Community-based Male Population of Northern Japan(Cerebrovascular circulation / Stroke-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Effort Angina in a Middle-Aged Woman With Abnormally High Levels of Serum High-Density Lipoprotein Cholesterol : A Case of Cholesteryl-Ester Transfer Protein Deficiency
- BNP Testing for Structural Heart Disease Screening in a Community-dwelling Population(Heart Failure, Clinical 6 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Increased Left Atrial Size is an Indicator of Accumulated Cardiovascular Risk Factors even in Apparently Healthy Subjects : A Community-Based Study(Preventive Medicine/Epidemiology/Education/Health Policy 4 (H), The 69th Annual Scientific Meeting of the J
- Impact of Anemia on Elevated Plasma BNP Level in the General Population(Neurohumoral Factors 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Impact of Increased Serum C-reactive Protein on Reduced Heart Rate Variability : a Community-based Study(Autonomic Nervous System 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Mortality and Incidence of Acute Myocardial Infarction and Coronary Death in a Rural Community-dwelling Population, Northern Iwate(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circ
- A Community-based Survey of Admission Cases of Congestive Heart Failure in Northern Iwate(Preventive Medicine/Epidemiology/Education/Health Policy 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-062 Elevated Plasma Level of Asymmetrical Dimethylarginine in Patients with Atrial Fibrillation : Possible Role for Cardiovascular Events(Arrhythmia, diagnosis/pathophysiology/EPS-3 (A) OJ11,Oral Presentation (Japanese),The 70th Anniversary Annual Scie
- Prospective Comparative Study of Intravenous Cibenzoline and Disopyramide Therapy in the Treatment of Paroxysmal Atrial Fibrillation After Cardiovascular Surgery
- Antithrombotic Therapy According to the Guidelines Issued by the Japanese Circulation Society in Patients with Nonvalvular Paroxysmal Atrial Fibrillation without Thromboembolic Risk Factors
- PJ-653 The Relationship between Long-term Preventive Effect of Antiarrhythmic Drug Therapy and Symptomatic Thromboembolism in Patients with Lone Paroxysmal Atrial Fibrillation(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70
- PJ-312 Different Efficacy of Combination Therapy with Antiarrhythmic Drugs and Enalapril between the Patients Groups with and without Underlying Heart Disease(Arrhythmia, therapy-14 (A) PJ53,Poster Session (Japanese),The 70th Anniversary Annual Scientific
- PE-021 The Combination Therapy with Antiarrhythmic Drugs and Pravastatin in Patients with Lone Atrial Fibrillation Prevents the Development of Structural Remodeling(Arrhythmia, diagnosis/pathophysiology/EPS-6 (A) PE4,Poster Session (English),The 70th Anni
- OJ-118 Long-term Prognosis of Antithrombotic Therapy According to Guideline Recommended by Japanese Circulation Society in Patients with non-valvular Paroxysmal Atrial Fibrillation(Thromboembolism/Antithrombotic therapy/Thrombolysis-2 (H) OJ20,Oral Presen
- Angiotensin Converting Enzyme Inhibitor Enhances Efficacy of Amiodarone and not Class-I Antiarrhythmic Drug in Preventing Recurrence of Paroxysmal Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 2 (A), The 69th Annual Scientific Meeting of the Jap
- Relationship between the Response to Antiarrhythmic Drug Therapy and the Development of Structural Remodeling in Patients with Paroxysmal Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 3 (A), The 69th Annual Scientific Meeting of the Japane
- Pravastatin Enhances the Efficacy of Class I Antiarrhythmic Agents in Patients with Paroxysmal Atrial Fibrillation and Hyperlipidemia(Arrhythmia, Non-pharmacological Therapy 8 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Efficacy of Antiarrhythmic Therapy in Preventing Recurrence of Paroxysmal Atrial Fibrillation not Showing Any Circadian Variation in the Onset(Arrhythmia, Pharmacological Therapy 1 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Societ
- Long-Term Prognosis of Patients With Paroxysmal Atrial Fibrillation Depends on Their Response to Antiarrhythmic Therapy
- Relationship Between the Long-Term Preventive Effect of Combined Treatment With Antiarrhythmic Drugs Plus Angiotensin-Converting Enzyme Inhibitors and Circadian Variation in the Onset of Paroxysmal Atrial Fibrillation
- Long-Term Efficacy of Amiodarone Therapy for the Prevention of Recurrence of Paroxysmal Atrial Fibrillation : Analysis Based on Patient Characteristics
- PJ-466 The Long-term Cardiovascular Prognosis of the Patients with Paroxysmal Atrial Fibrillation Depends on Their Response to Antiarrhythmic Drugs Therapy(Arrhythmia, therapy-17 (A) PJ79,Poster Session (Japanese),The 70th Anniversary Annual Scientific Me
- Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation : A Multicenter Study of Its Status and Influential Factors
- Combination Therapy With Amiodarone and Enalapril in Patients With Paroxysmal Atrial Fibrillation Prevents the Development of Structural Atrial Remodeling
- Tuberculous Retropharyngeal Abscess Associated with Spinal Tuberculosis Well Controlled by Fine-needle Aspiration and Anti-tuberculous Chemotherapy
- Practical Issue of Pharmacological Management in Paroxysmal Atrial Fibrillation Patients Treated with Anticoagulant Therapy
- Long-term Efficacy of Upstream Therapy With Lipophilic or Hydrophilic Statins on Antiarrhythmic Drugs in Patients With Paroxysmal Atrial Fibrillation Comparison Between Atorvastatin and Pravastatin:Comparison Between Atorvastatin and Pravastatin
- Relationship Between CHADS2 Score and Efficacy of Antiarrhythmic Drug Therapy in Patients With Paroxysmal Atrial Fibrillation
- Long-Term Efficacy of Upstream Therapy Using Angiotensin-Converting Enzyme Inhibitors and Statins in Combination With Antiarrhythmic Agents for the Treatment of Paroxysmal Atrial Fibrillation